Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/3/2025

STI Testing for Young Adults

Optimal Testing Approach

  • The American Academy of Pediatrics recommends first-void urine using nucleic acid amplification tests (NAATs) as the optimal specimen type for detecting chlamydia and gonorrhea in young males 1, 2
  • NAATs are the preferred testing method for chlamydia and gonorrhea, offering superior sensitivity and specificity compared to older culture methods, regardless of symptoms 1, 2
  • Urine collection is non-invasive, patient-friendly, and can be self-collected, which enhances screening participation 1

Risk-Based Specimen Collection

  • For standard heterosexual males, urine NAAT for chlamydia and gonorrhea is sufficient for routine screening 1, 2
  • Blood tests for syphilis and HIV should be considered based on individual risk factors 3, 4
  • For men who have sex with men (MSM), testing must be site-specific based on sexual practices, including urine NAAT for urethral infection, rectal swab NAAT for receptive anal intercourse, and pharyngeal swab NAAT for receptive oral intercourse 1, 3, 5

Important Clinical Considerations

  • The Centers for Disease Control and Prevention (CDC) recommends screening for syphilis, HIV, and hepatitis B based on individual risk factors 3, 6
  • Immediate testing can detect bacterial STIs even shortly after exposure, and follow-up testing at 3 months is essential for HIV and syphilis due to window periods 6
  • Rescreening at 3 months is recommended if initially positive for chlamydia or gonorrhea due to high reinfection rates 1, 3, 5

Practical Implementation

  • For routine screening of an asymptomatic young adult, collect first-void urine for chlamydia/gonorrhea NAAT, and draw blood for syphilis serology if risk factors are present 1, 2, 3
  • Offer HIV testing based on risk assessment, and consider expanded testing for Mycoplasma genitalium and Trichomonas vaginalis in high-prevalence populations or symptomatic patients 6, 5

Comprehensive Sexual Health Testing for Young Adults

Core Testing Panel

  • The Centers for Disease Control and Prevention recommends syphilis serology and HIV testing through blood tests, with appropriate counseling, for individuals at risk 7, 8
  • The Centers for Disease Control and Prevention suggests hepatitis B and C serologic testing based on risk assessment, particularly for those with a history of injection drug use or multiple partners 7

Risk-Based Assessment and Additional Testing

  • The Centers for Disease Control and Prevention recommends rescreening at 3 months if initially positive for chlamydia or gonorrhea due to high reinfection rates of up to 39% in young adults 9
  • The Centers for Disease Control and Prevention advises that if any test is positive, sex partners must be evaluated and treated to prevent reinfection 9

Practical Implementation

  • The American College of Physicians and the Centers for Disease Control and Prevention recommend annual screening at minimum for all sexually active males at risk for STDs 7, 9
  • The Centers for Disease Control and Prevention suggests that more frequent testing may be indicated for certain high-risk groups, although specific guidelines are not provided in the cited references 7, 9